BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  Celltrion USA completes submission of Biologics License Application for CT-P47, a biosimilar candidate of ACTEMRA® (tocilizumab)

  Celltrion USA announced the submission of Biologics License Application to the U.S. Food and Drug Administration for CT-P47, a biosimilar candidate of the reference product ACTEMRA®.

  January 28, 2024

   · 

  4 min read
• Drug Development

  Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

  Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced new data presented at the 60th Annual Meeting of The Society of Thoracic Surgeons.

  January 28, 2024

   · 

  4 min read